R115777 in Treating Patients With Advanced Bladder Cancer

Completed · Phase 2

Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have advanced bladder cancer.

Key facts

Study ID

NCT00006376

Run by

H. Lee Moffitt Cancer Center and Research Institute

Starts

2000-03-01

Expected to finish

2005-05-01

Last updated by the study team

2013-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.